Filing Details
- Accession Number:
- 0001103780-16-000084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-19 17:29:11
- Reporting Period:
- 2010-01-20
- Filing Date:
- 2016-07-19
- Accepted Time:
- 2016-07-19 17:29:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1348362 | Lexaria Bioscience Corp. | LXRP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1103780 | Christopher Bunka | 1924 Birkdale Ave Kelowna A1 V1P1R7 | Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2016-07-18 | 7,000 | $0.14 | 7,100,619 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 4,971,844 | Indirect | Private holding company |
| Common Shares | 7,093,619 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Options | $0.10 | 2014-12-23 | 2019-12-23 | 550,000 | 550,000 | Direct |
| Common Shares | Stock Options | $0.09 | 2013-06-18 | 2018-06-18 | 247,500 | 797,500 | Direct |
| Common Shares | Warrants | $0.23 | 2015-05-15 | 2017-05-15 | 187,000 | 187,000 | Indirect |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2019-12-23 | 550,000 | 550,000 | Direct |
| 2018-06-18 | 247,500 | 797,500 | Direct |
| 2017-05-15 | 187,000 | 187,000 | Indirect |
Billionaire Hedge Funds
